Immuneering Corporation
IMRX
$6.74
$0.050.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.86% | 7.26% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.22% | -4.69% | |||
| Operating Income | -4.22% | 4.69% | |||
| Income Before Tax | -3.68% | 4.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.68% | 4.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.68% | 4.07% | |||
| EBIT | -4.22% | 4.69% | |||
| EBITDA | -4.28% | 4.72% | |||
| EPS Basic | 5.96% | 5.29% | |||
| Normalized Basic EPS | 5.94% | 5.29% | |||
| EPS Diluted | 5.96% | 5.29% | |||
| Normalized Diluted EPS | 5.94% | 5.29% | |||
| Average Basic Shares Outstanding | 10.24% | 1.28% | |||
| Average Diluted Shares Outstanding | 10.24% | 1.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||